Approval · Notice of Compliance 8820 · 2007
ACYCLOVIR SODIUM INJECTION: Notice of Compliance 8820
Issued June 7, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8820
- Date
- June 7, 2007
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZOVIRAX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR SODIUM INJECTION | 02236916 | Cancelled Post Market |
Medicinal ingredients
- ACYCLOVIR SODIUM 25 MG per ML